Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P69
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 46.84% |
| Q2 2025 | 13.48% |
| Q1 2025 | -248.79% |
| Q4 2024 | 177.19% |
| Q3 2024 | 1.13% |
| Q2 2024 | 70.99% |
| Q1 2024 | -379.56% |
| Q4 2023 | -112.20% |
| Q3 2023 | 325.34% |
| Q2 2023 | 19.96% |
| Q1 2023 | 4.34% |
| Q4 2022 | -5.30% |
| Q3 2022 | -32.90% |
| Q2 2022 | -704.28% |
| Q1 2022 | 90.20% |
| Q4 2021 | 28.38% |
| Q3 2021 | 8.12% |
| Q2 2021 | -2452.65% |
| Q1 2021 | -83.87% |
| Q4 2020 | 1417.15% |
| Q3 2020 | -84.47% |
| Q2 2020 | -22.78% |
| Q1 2020 | 0.00% |
| Q3 2019 | -238.43% |
| Q2 2019 | 74.01% |
| Q1 2019 | 11.03% |
| Q4 2018 | -7.92% |
| Q3 2018 | -207.61% |
| Q2 2018 | 62.70% |
| Q1 2018 | -6.06% |
| Q4 2017 | 69.85% |
| Q3 2017 | -362.43% |
| Q2 2017 | -27.82% |
| Q1 2017 | -281.89% |
| Q4 2016 | 69.60% |
| Q3 2016 | 54.33% |
| Q2 2016 | -97.52% |
| Q1 2016 | 63.90% |
| Q4 2015 | -389.41% |
| Q3 2015 | 48.46% |